Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126585063 | 12658506 | 3 | F | 201210 | 20160826 | 20160817 | 20160901 | EXP | PHHY2014MX163013 | NOVARTIS | 64.78 | YR | M | Y | 63.00000 | KG | 20160901 | MD | MX | MX |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126585063 | 12658506 | 1 | PS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | PATCH (5 CM2), QD | 468110 | 22083 | 4.6 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | |||||
| 126585063 | 12658506 | 2 | SS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | (PATCH 10 CM2), QD | 22083 | 9.5 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | ||||||
| 126585063 | 12658506 | 3 | SS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 2 DF (2 PATCHES OF 5 CM2), QD | 22083 | 2 | DF | TRANS-THERAPEUTIC-SYSTEM | QD | ||||||
| 126585063 | 12658506 | 4 | SS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | PATCH (5 CM2), QD | 22083 | 4.6 | MG | TRANS-THERAPEUTIC-SYSTEM | QD | ||||||
| 126585063 | 12658506 | 5 | SS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | UNK | 22083 | TRANS-THERAPEUTIC-SYSTEM | |||||||||
| 126585063 | 12658506 | 6 | SS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | UNK | 22083 | TRANS-THERAPEUTIC-SYSTEM | |||||||||
| 126585063 | 12658506 | 7 | C | AKATINOL | 2 | Oral | 20 MG, QD | 0 | 20 | MG | TABLET | QD | |||||||
| 126585063 | 12658506 | 8 | C | AKATINOL | 2 | 0 | TABLET | ||||||||||||
| 126585063 | 12658506 | 9 | C | VITAMIN E | .ALPHA.-TOCOPHEROL | 1 | Unknown | 400 MG, QD (IN THE MORNING) | U | 0 | 400 | MG | QD | ||||||
| 126585063 | 12658506 | 10 | C | BENEXAFRINE | 2 | Unknown | 5 MG, QHS | U | 0 | 5 | MG | ||||||||
| 126585063 | 12658506 | 11 | C | ATACAND | CANDESARTAN CILEXETIL | 1 | Oral | 2 MG, UNK (MONDAY,WEDNESDAY AND FRIDAY 8 YEARS AGO) | 0 | 2 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126585063 | 12658506 | 1 | Dementia Alzheimer's type |
| 126585063 | 12658506 | 2 | Cerebrovascular accident |
| 126585063 | 12658506 | 7 | Cerebral disorder |
| 126585063 | 12658506 | 8 | Senile dementia |
| 126585063 | 12658506 | 9 | Cerebral disorder |
| 126585063 | 12658506 | 10 | Product used for unknown indication |
| 126585063 | 12658506 | 11 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126585063 | 12658506 | DS |
| 126585063 | 12658506 | OT |
| 126585063 | 12658506 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126585063 | 12658506 | Abasia | |
| 126585063 | 12658506 | Aggression | |
| 126585063 | 12658506 | Blood pressure increased | |
| 126585063 | 12658506 | Clumsiness | |
| 126585063 | 12658506 | Confusional state | |
| 126585063 | 12658506 | Decreased interest | |
| 126585063 | 12658506 | Dementia Alzheimer's type | |
| 126585063 | 12658506 | Depression | |
| 126585063 | 12658506 | Drug ineffective | |
| 126585063 | 12658506 | Drug prescribing error | |
| 126585063 | 12658506 | Fall | |
| 126585063 | 12658506 | General physical health deterioration | |
| 126585063 | 12658506 | Haemorrhage | |
| 126585063 | 12658506 | Incoherent | |
| 126585063 | 12658506 | Insomnia | |
| 126585063 | 12658506 | Irritability | |
| 126585063 | 12658506 | Joint swelling | |
| 126585063 | 12658506 | Memory impairment | |
| 126585063 | 12658506 | Middle insomnia | |
| 126585063 | 12658506 | Muscular weakness | |
| 126585063 | 12658506 | Musculoskeletal chest pain | |
| 126585063 | 12658506 | Pain in extremity | |
| 126585063 | 12658506 | Peripheral swelling | |
| 126585063 | 12658506 | Pneumonia | |
| 126585063 | 12658506 | Product use issue | |
| 126585063 | 12658506 | Productive cough | |
| 126585063 | 12658506 | Sedation | |
| 126585063 | 12658506 | Somnolence | |
| 126585063 | 12658506 | Sputum retention | |
| 126585063 | 12658506 | Stubbornness | |
| 126585063 | 12658506 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126585063 | 12658506 | 1 | 201210 | 0 | ||
| 126585063 | 12658506 | 2 | 2012 | 0 | ||
| 126585063 | 12658506 | 3 | 20141204 | 0 | ||
| 126585063 | 12658506 | 4 | 201505 | 0 | ||
| 126585063 | 12658506 | 5 | 201601 | 0 | ||
| 126585063 | 12658506 | 6 | 201608 | 0 | ||
| 126585063 | 12658506 | 7 | 2012 | 0 | ||
| 126585063 | 12658506 | 9 | 20141204 | 0 |